In this “Meet the Expert” conversation, hepatologist Dr. Robert G. Gish joins Blue Faery — The Adrienne Wilson Liver Cancer Association — to talk through liver cancer risk, surveillance, and the case for catching the disease early.
About the conversation
Blue Faery — The Adrienne Wilson Liver Cancer Association is a nonprofit devoted to preventing, treating, and curing primary liver cancer through research, education, and patient advocacy. Its “Meet the Expert” series brings leading clinicians directly to the patients, families, and caregivers who need their guidance most.
In this session, hepatologist Dr. Robert G. Gish — one of the most recognized voices in liver disease — offers a clear, approachable primer on hepatocellular carcinoma (HCC), the most common form of liver cancer, and why catching it early changes everything.
What Dr. Gish covers
- Who is most at risk for HCC — and why cirrhosis and chronic liver disease matter so much
- What liver cancer surveillance involves, and how often at-risk patients should be screened
- Why so many cases are still caught late, when treatment options are limited
- How earlier detection opens the door to more — and more curative — care
Why it matters
Liver cancer is too often diagnosed at an advanced stage, when curative treatment is hardest to offer. Conversations like this one exist to change that: the more patients and caregivers understand their risk and stay on top of surveillance, the earlier disease can be found — and the better the odds. It’s a message at the heart of both Blue Faery’s mission and Helio’s work on simpler, blood-based early detection.
Watch the full conversation on LinkedIn here.